PharmaShots | Incisive News in 3 Shots

Subscribe Now

Pregene

Pregene Signs an Exclusive License Agreement with CellPoint to Develop and Commercialize PRG-1801 for the Treatment of R/R Multiple Myeloma

Pregene Signs an Exclusive License Agreement with CellPoint to Develop and Commercialize PRG-1801 for the Treatment of R/R Multipl...

April 7, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us